Keros Therapeutics (KROS) delivered earnings and revenue surprises of 36,300% and 149.64%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on ...

Warren Buffett says that if he were to start again, he’d look for old-fashioned value stocks. Stephen Wright thinks there’s an unusual one on offer. The post Why I’m considering considering breaking ...

The Golden Eagles (34-13 overall, 17-6 Sun Belt) won their eighth-straight contest as they tossed their third shutout of the ...

Investors in Keros Therapeutics, Inc. KROS need to pay close attention to the stock based on moves in the options market lately. That is because the May 16, 2025 $70.00 Call had some of the highest ...

The Golden Eagles (32-13) won for the sixth consecutive game as they ended their non-conference schedule with a 17-7 mark.

Bryce Calloway homered in the first inning and the New Orleans Privateers pushed the #22 Southern Miss Golden Eagles to the ...

Kairos Pharma (NYSE American: KAPA) , announced it will present new data on KROS 101, a small molecule GITR ligand agonist, at the 2025 American Soci ...

Over appetizers, drinks and good conversation, CASA of the Mid-Shore thanked its volunteers Thursday with a special event at ...

For the second time in eight days, Golden Eagle second baseman Nick Monistere hit a game-winning home run to defeat Southeastern (31-10).

Morton’s toe is a common foot structure where the second toe is longer than the first (big) toe. As it affects weight distribution, some people may experience pain. Home treatments can help ...

Leqembi (lecanemab) has won marketing authorization in the European Union for the treatment of certain adults with early Alzheimer’s disease, making it the first therapy that targets an underlying ...